In India, the incidence of breast cancer is 25.8 in 100000 women each year with a mortality rate of 12.7 out of every 100000 ...

For patients with high-risk, early-stage estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

Individual patient data from neoadjuvant randomized breast cancer clinical trials with available data on pathologic complete ...

A far shorter, simpler, and less toxic treatment protocol for patients with triple-negative breast cancer produced outcomes ...

A Peter Mac-led international clinical trial has shown adding an immunotherapy drug to the chemotherapy that patients receive ...

A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...

A revolutionary new treatment for breast cancer has shown the ability to eliminate small breast tumors and significantly ...

Despite significant therapeutic advances, breast cancer remains a leading cause ... noted that a single dose of ErSO-TFPy in mice induced complete or near-complete regression of small or large ...

“We haven’t seen any new therapy increase the pathological complete response (pCR) in this group of breast cancer patients before. In this trial we observed a massive increase.” The pCR ...

Breast cancer and breast cancer treatments, such as chemotherapy and hormone therapies, can contribute to fatigue. Some ways to manage it can include getting aerobic exercise, practicing ...

They were wrong. Ms. Donovan, who was 33 at the time, had metastatic breast cancer that had spread to her bones. “I was really just in shock,” she said, adding that back then she didn’t even ...